Distinct regulation of T-cell death by CD28 depending on both its aggregation and T-cell receptor triggering: A role for Fas-FasL

Blood

Volumn 92, Issue 4, 1998, Pages 1350-1363

  Collette, Y ^a   Benziane, A ^a   Razanajaona, D ^a   Olive, D ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; FAS ANTIGEN; T LYMPHOCYTE RECEPTOR;

APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL DEATH; DOSE RESPONSE; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0032529317     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.4.1350.416k24_1350_1363     Document Type: Article

References (74)

1. Ellis RE, Yuang JY, Horvitz HR: Mechanisms and functions of cell cycle death. Annu Rev Cell Biol 7:633, 1991
2. Dent AL, Matis LA, Hooshmand F, Widacki SM, Bluestone JA, Hedrick SM: Self-reactive gamma delta T cells are eliminated in the thymus. Nature 343:714, 1990
3. MacDonald HR, Lees RK: Programmed death of autoreactive thymocytes. Nature 343:642, 1990
4. Nossal GJV: Negative selection of lymphocytes. Cell 76:229, 1994
5. Osborne BA: Apoptosis and the maintenance of homeostasis in the immune system. Curr Opin Immunol 8:245, 1996
6. Henkart PA: ICE family proteases: Mediators of all apoptotic cell death? Immunity 4:195, 1996
7. Stasser A: Life and death during lymphocyte development and function: Evidence for two distinct killing mechanisms. Curr Opin Immunol 7:228, 1995
8. Sarin A, Adams DH, Henkart PA: Protease inhibitors selectively block T cell receptor-triggered programmed cell death in a murin T cell hybridoma and activated peripheral T cells. J Exp Med 178:1693, 1993
9. Kuida K, Lippke JA, Ku G, Harding GW, Livingston DJ, Su MS, Flavell RA: Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science 267:2000, 1995
10. Shi L, Kam CM, Powers JC, Aebersold R, Greenberg AH: Purification of three cytotoxic lymphocyte granule serine proteases that induce apoptosis through distinct substrate and target cell interactions. J Exp Med 176:1521, 1992
11. Gajewski TF, Thompson CB: Apoptosis meets signal transduction: Elimination of a Bad influence. Cell 87:589, 1996
12. Yang E, Korsmeyer SJ: Molecular thanatopsis: A discourse on the BCL2 family and cell death. Blood 88:386, 1996
13. Osborne BA, Schwartz LM: Essential genes that regulate apoptosis. Trends Cell Biol 4:394, 1994
14. Yang E, Zha J, Jockel J, Boise LH, Thompson CB, Korsmeyer SJ: Bad, a heterodimeric partner for Bel-XL and Bcl-2, displaces Bax and promotes cell death. Cell 80:285, 1995
15. Knudson CM, Korsmeyer SJ: Bcl-2 and Bax function independently to regulate cell death. Nat Genet 16:358, 1997
16. Boyd JM, Gallo GJ, Elangovan B, Houghton AB, Malstrom S, Avery BJ, Ebb RG, Subramanian T, Chittenden T, Lutz RJ, et al: Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins. Oncogene 11:1921, 1995
17. Cheng EH, Nicholas J, Bellows DS, Hayward GS, Guo HG, Reitz MS, Hardwick JM: A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpes virus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak. Proc Natl Acad Sci USA 94:690, 1997
18. Smith CA, Williams GT, Kingston R, Jenkinson EJ, Owen JJT: Antibodies to CD3/T cell receptor complex induce death by apoptosis in immature T cells in thymic culture. Nature 337:181, 1989
19. + T cells in mice tolerant to staphyloccocus aureus enterotoxin b. Nature 349:245, 1991
20. Gonzalo JA, Alboran IMD, Ales-Martinez JE, Martinez AC, Kroemer G: Expansion and clonal deletion of peripheral T cells induced by bacterial superantigen is independent of the interleukin-2 pathway. Eur J Immunol 22:1007, 1992
21. Lenardo MJ: Interleukin-2 programs mouse alpha/beta lymphocytes for apoptosis. Nature 353:858, 1991
22. Radvanyi LG, Mills GB, Miller RG: Relegation of the T cell receptor after primary activation of mature T cells inhibits proliferation and induces apoptotic cell death. J Immunol 150:5704, 1993
23. Wesselborg S, Janssen O, Kabelitz D: Induction of activation-driven death (apoptosis) in activated but not resting peripheral blood T cells. J Immunol 150:4338, 1993
24. Russell JH, Rush B, Weaver C, Wang R: Mature T cells of autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide. Proc Natl Acad Sci USA 90:4409, 1993
25. Dhein J, Walczak H, Baumler C, Debatin KM, Krammer PH: Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 373:438, 1995
26. Brunner T, Mogil RG, Laface D, Yoo NJ, Mahoubl A, Echeverri F, Martin SJ, Force WR, Lynch DH, Ware CF, Green DR: Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373:441, 1995
27. Smith CA, Farrah T, Goodwin RG: The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death. Cell 76:959, 1994
28. Nagata S, Goldstein P: The Fas death factor. Science 267:1449, 1995
29. Fraser A, Evan G: A license to kill. Cell 85:781, 1996
30. Yang Y, Mercep M, Ware CF, Ashwell JD: Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: Inhibition of Fas ligand expression by retinoic acid and glucocorticoids. J Exp Med 181:1673, 1995
31. Castro JE, Listman JA, Jacobson BA, Wang Y, Lopez PA, Ju S, Finn PW, Perkins DL: Fas modulation of apoptosis during negative selection of thymocytes. Immunity 5:617, 1996
32. Sytwu HK, Liblau RS, McDevitt HO: The roles of Fas/APO-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice. Immunity 5:17, 1996
33. June CH, Bluestone JA, Nadler LM, Thompson CB: The B7 and CD28 receptor families. Immunol Today 15:321, 1994
34. Guinan EC, Gribben JG, Boussiotis VA, Freeman GJ, Nadler LM: Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity. Blood 84:3261, 1994
35. Olive D, Pages F, Klasen S, Battifora M, Costello R, Nunes J, Truneh A, Ragueneau M, Martin Y, Imbert J, Birg F, Mawas C, Bagnasco M, Cerdan C: Stimulation via the CD28 molecule. Regulation of signalling, cytokine production and cytokine receptor expression. [Review]. Fundam Clin Immunol 2:185, 1994
36. + thymocytes by T cell receptor-induced apoptosis requires a costimulatory signal that can be provided by CD28. J Exp Med 179:709, 1994
37. Kishimoto H, Cai ZL, Brunmark A, Jackson MR, Peterson PA, Sprent J: Differing roles for b7 and intercellular adhesion molecule-1 in negative selection of thymocytes. J Exp Med 184:531, 1996
38. Boise LH, Minn AJ, Noel PJ, June CH, Accavitti MA, Lindsten T, Thompson CB: CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. Immunity 3:87, 1995
39. Boise LH, Noel PJ, Thompson CB: CD28 and apoptosis. Curr Opin Immunol 7:620, 1995
40. Boussiotis VA, Lee BJ, Freeman GJ, Gribben JG, Nadler LM: Induction of T cell clonal anergy results in resistance, whereas CD28-mediated costimulation primes for susceptibility to Fas-and Bax-mediated programmed cell death. J Immunol 159:3156, 1997
41. Lin RH, Hwang YW, Yang BC, Lin CS: TNF receptor-2-triggered apoptosis is associated with the down-regulation of Bcl-xL on activated T cells and can be prevented by CD28 costimulation. J Immunol 158:598, 1997
42. Pages F, Ragueneau M, Klasen S, Battifora M, Couez D, Sweet R, Truneh A, Ward SG, Olive D: Two distinct intracytoplasmic regions of the T-cell adhesion molecule CD28 participate in phosphatidylinositol 3-kinase association. J Biol Chem 271:9403, 1996
43. Collette Y, Razanajaona D, Ghiotto M, Olive D: CD28 can promote T cell survival through a phosphatidylinositol 3-kinase-independent mechanism. Eur J Immunol 27:3283, 1997
44. Nunes J, Klasen S, Franco MD, Lipcey C, Mawas C, Bagnasco M, Olive D: Signalling through CD28 T-cell activation pathway involves an inositol phospholipid-specific phospholipase C activity. Biochem J 293:835, 1993
45. Nunes JA, Collette Y, Truneh A, Olive D, Cantrell DA: The role of p21ras in CD28 signal transduction: Triggering of CD28 with antibodies, but not the ligand B7-1, activates p21ras. J Exp Med 180:1067, 1994
46. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Meth 139:271, 1991
47. Gong J, Traganos F, Darzynkiewicz Z: A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry. Anal Biochem 218:314, 1994
48. Collette Y, Chang HL, Cerdan C, Chambost H, Algarte M, Mawas C, Imbert J, Burny A, Olive D: Specific Th1 cytokine down-regulation associated with primary clinically derived human immunodeficiency virus type 1 nef gene-induced expression. J Immunol 156:360, 1996
49. Ucker DS, Ashwell JD, Nickas G: Activation-driven T cell death. Requirements for de novo transcription and translation and association with genome fragmentation. J Immunol 143:3461, 1989
50. Odaka C, Kizaki H, Tadakuma T: T cell receptor-mediated DNA fragmentation and cell death in T cell hybridomas. J Immunol 144: 2096, 1990
51. Shi Y, Szalay MG, Paskar L, Boyer M, Singh B, Green DR: Activation induced cell death in T cell hybridomas is due to apoptosis: Morphological aspects and DNA fragmentation. J Immunol 144:3326, 1990
52. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, Munday NA, Raju SM, Smulson ME, Yamin T-T, Yu VL, Miller DK: Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376:37, 1995
53. Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zeng Z, Beidler DR, Poirier GG, Salvesen GS, Dixit VM: Yama/CPP32b, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate Poly (ADP-Ribose) polymerase. Cell 81:1, 1995
54. + thymocytes by two distinct mechanisms differing in their requirement for CD28 costimulation: Implications for negative selection in the thymus. J Exp Med 186:1911, 1997
55. Mueller DL, Seiffert S, Fang W, Behrens TW: Differential regulation of bcl-2 and Bcl-X by CD3, CD28, and the IL-2 receptor in cloned CD4(+) helper T cells - A model for the long-term survival of memory cells. J Immunol 156:1764, 1996
56. Nagata S: Apoptosis by death factor. [Review] [85 refs]. Cell 88:355, 1997
57. Wong B, Arron J, Choi Y: T cell receptor signals enhance susceptibility to Fas-mediated apoptosis. J Exp Med 186:1939, 1997
58. Hornung F, Zheng L, Lenardo MJ: Maintenance of clonotype specificity in CD95/Apo-1/Fas-mediated apoptosis of mature T lymphocytes. J Immunol 159:3816, 1997
59. Chen L, Linsley PS, Hellstrom KE: Costimulation of T cells for tumor immunity. Immunol Today 14:483, 1993
60. + T cells. Science 276:273, 1997
61. Chen L, Ashe S, Brady WA, Hellstrom I, Hellstrom KE, Ledbetter JA, McGowan P, Linsley PS: Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell 71:1093, 1992
62. + T cells by B7-transfected melanoma cells [see comments]. Science 259:368, 1993
63. + T cells by delivery of the B7 costimulatory signal on bystander antigen-presenting cells (trans-costimulation). Eur J Immunol 24:859, 1994
64. Yang X, Khosravi FR, Chang HY, Baltimore D: Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell 89:1067, 1997
65. Sieg S, Yildirim Z, Smith D, Kayagaki N, Yagita H, Huang Y, Kaplan D: Herpes simplex virus type 2 inhibition of Fas ligand expression. J Virol 70:8747, 1996
66. Anel A, Buferne M, Boyer C, Schmitt VA, Golstein P: T cell receptor-induced Fas ligand expression in cytotoxic T lymphocyte clones is blocked by protein tyrosine kinase inhibitors and cyclosporin A. Eur J Immunol 24:2469, 1994
67. Gonzalez GA, Borlado L, Leonardo E, Merida I, Martinez AC, Carrera AC: Lck is necessary and sufficient for Fas-ligand expression and apoptotic cell death in mature cycling T cells. J Immunol 158:4104, 1997
68. Chung CD, Lewis LA, Miceli MC: T cell antigen receptor-induced IL-2 production and apoptosis have different requirements for Lck activities. J Immunol 159:1758, 1997
69. Latinis KM, Can LL, Peterson EJ, Norian LA, Eliason SL, Koretzky GA: Regulation of CD95 (Fas) ligand expression by TCR-mediated signaling events. J Immunol 158:4602, 1997
70. Hodge MR, Ranger AM, Charles de la Brousse F, Hoey T, Grusby MJ, Glimcher LH: Hyperproliferation and dysregulation of IL-4 expression in NF-ATp-deficient mice. Immunity 4:397, 1996
71. Xanthoudakis S, Viola JP, Shaw KT, Luo C, Wallace JD, Bozza PT, Luk DC, Curran T, Rao A: An enhanced immune response in mice lacking the transcription factor NFAT1 [published erratum appears in Science 273:5280, 1996]. Science 272:892, 1996
72. Hahne M, Rimoldi D, Schroter M, Romero P, Schreier M, French LE, Schneider P, Bornand T, Fontana A, Lienard D, Cerottini J, Tschopp J: Melanoma cell expression of Fas(Apo-1/CD95) ligand: Implications for tumor immune escape [see comments]. Science 274:1363, 1996
73. June CH, Vandenberghe P, Thompson CB: The CD28 and CTLA-4 receptor family. Chem Immunol 59:62, 1994
74. Loetscher P, Seitz M, Baggiolini M, Moser B: Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes. J Exp Med 184:569, 1996